• Vaccine Name: Influenza A (H1N1) 2009 Monovalent Vaccine from Sanofi Pasteur
• Target Pathogen: Influenza virus
• Target Disease: Influenza (flu)
• Product Name: Influenza A (H1N1) 2009 Monovalent Vaccine
• Manufacturer: Sanofi Pasteur
• Vaccine Ontology ID: VO_0000160
• Type: Inactivated or "killed" vaccine
• Status: Licensed
• Location Licensed: USA
• Host Species for Licensed Use: Human
• Antigen: 2009 Pandemic H1N1 Influenza Virus
• Preparation: Prepared from influenza viruses propagated in embryonated chicken eggs. The virus-containing allantoic fluid is harvested and inactivated with formaldehyde. Influenza virus is then concentrated and purified in a linear sucrose density gradient solution. The processed virus is chemically disrupted using a non-ionic surfactant, polyethylene glycol p-isooctylphenyl ether (Triton X-100), producing a “split virus”. The split virus is further purified and then suspended in sodium phosphate-buffered isotonic sodium chloride solution (FDA: H1N1 Vaccine Sanofi Pasteur).
• Immunization Route: Intramuscular injection (i.m.)
• Virulence: Inactivated
• Storage: store at 2−8°C (36−46°F)
• Approved Age for Licensed Use: Persons aged 6 months and older.
• Contraindication: Severe hypersensitivity to egg proteins and any component of the vaccine, or life-threatening reactions after previous administration of any influenza vaccine (FDA: H1N1 Vaccine Sanofi Pasteur).

Human Response

• Side Effects: Most common side effects were soreness at the injection site, tenderness, pain and swelling. Common systemic side effects are malaise, headache and myalgia (FDA: H1N1 Vaccine Sanofi Pasteur).